Table 1.
Serum biochemical parameters and liver hydroxyproline content of control, model, and YCHT-treated rats.
| Parameter | Control | Model | YCHT |
|---|---|---|---|
| Serum | |||
| ALT (U/L) | 30.94 ± 8.07 | 90.07 ± 24.39 ** | 73.8 ± 9.89 ∆∆ |
| AST (U/L) | 55.06 ± 5.23 | 101.43 ± 16.53 ** | 83.3 ± 7.14 ∆∆ |
| Alb (g/L) | 30.48 ± 2.59 | 25.20 ± 2.42 ** | 27.65 ± 2.11 ∆ |
| GGT (U/L) | 95.22 ± 14.12 | 178.26 ± 37.11 ** | 127.39 ± 10.99 ∆∆ |
| ALP (king/100 mL) | 24.97 ± 4.03 | 92.76 ± 28.62 ** | 74.82 ± 13.75 ∆ |
| TBil (mg/dL) | 0.38 ± 0.11 | 0.58 ± 0.11 ** | 0.41 ± 0.06 ∆∆ |
| Liver | |||
| Hydroxyproline (μg/g) | 210.48 ± 65.21 | 463.75 ± 156.72 ** | 307.91 ± 95.06 ∆∆ |
Data are represented as mean ± SD (n = 15 in each group). ** p < 0.01, vs. control group; ∆ p < 0.05, ∆∆ p < 0.01, vs. model group from one-way ANOVA analysis.